Nilotinib


#1
http://www.eurekalert.org/pub_releases/2013-05/gumc-cdp050313.php
This compound is in use for the treatment of leukemia so all its toxicity data is well known. It can go straight into phase 2 clinical trials for PD.........

#2
sounds very promising....but as always we shall have to wait and see.
thanks

#3
ps you are no 7 in a google searck om recent nilotnib stories - fame at last!

#4
headline
Nilotinib [u]reverses[/u] loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models

http://hmg.oxfordjournals.org/content/early/2013/05/09/hmg.ddt192.abstract?sid=b45c60fd-bf7c-4014-a2e6-d0f133651625

#5
ps translation
this drugs causes the brain's vacuum cleaners to sweep up rogue proteins which revitalises inactive neurons

#6
or to put it another way
IF THIS WORKS EVERY NEURO-DEGENERATIVE DISEASE STOPS GETTING WORSE AND COULD EVEN IMPROVE
of course it might not... but this just could be the big one.